farnesol has been researched along with thapsigargin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bychkov, R; Chapman, J; Haller, H; Luft, FC; Luft, UC; McCarron, DA; Roullet, CM; Roullet, JB; Xue, H | 1 |
| Rosado, JA; Sage, SO | 2 |
3 other study(ies) available for farnesol and thapsigargin
| Article | Year |
|---|---|
Farnesol inhibits L-type Ca2+ channels in vascular smooth muscle cells.
Topics: Animals; Arteries; Calcium; Calcium Channel Blockers; Cells, Cultured; Drug Interactions; Farnesol; In Vitro Techniques; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Rats; Signal Transduction; Tetradecanoylphorbol Acetate; Thapsigargin | 1997 |
Farnesylcysteine analogues inhibit store-regulated Ca2+ entry in human platelets: evidence for involvement of small GTP-binding proteins and actin cytoskeleton.
Topics: Actins; Blood Platelets; Calcium; Cysteine; Cytochalasin D; Cytoskeleton; Diterpenes; Farnesol; Humans; In Vitro Techniques; Kinetics; Monomeric GTP-Binding Proteins; Phosphotyrosine; Protein Methyltransferases; Protein Prenylation; Thapsigargin; Thrombin | 2000 |
Role of the ERK pathway in the activation of store-mediated calcium entry in human platelets.
Topics: Actins; Benzamides; Blood Platelets; Butadienes; Calcium; Cytochalasin D; Enzyme Activation; Enzyme Inhibitors; Farnesol; Humans; In Vitro Techniques; Kinetics; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Nitriles; Platelet Activation; Thapsigargin; Thrombin | 2001 |